JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olayioye, M. A.
Right arrow Articles by Hynes, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olayioye, M. A.
Right arrow Articles by Hynes, N. E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 24, 17209-17218, June 11, 1999

ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases

Monilola A. Olayioye, Iwan Beuvink, Kay Horsch, John M. Daly, and Nancy E. Hynes

From the Friedrich Miescher Institute, P.O. Box 2543, CH-4002 Basel, Switzerland

Epidermal growth factor (EGF) binding to its receptor, ErbB1, triggers various signal transduction pathways, one of which leads to the activation of signal transducer and activator of transcription (Stat) factors. The mechanism underlying ErbB1-induced Stat activation and whether Stats are downstream targets of other ErbB receptors have not been explored. In this report we show that ErbB2, ErbB3, and ErbB4 do not potentiate Stat5 phosphorylation by EGF. However, neu differentiation factor-induced heterodimers of ErbB2 and ErbB4 activated Stat5. In A431 cells, Stat1, Stat3, and Stat5, were constitutively complexed with ErbB1 and rapidly phosphorylated on tyrosine in response to EGF. Neither mutation of the conserved tyrosine residue (Tyr694) nor inactivation of the Stat5a SH2 domain disrupted this association. However, an intact SH2 domain was necessary for EGF-induced Stat5a phosphorylation. In contrast to prolactin, which induced only Tyr694 phosphorylation of Stat5a, EGF promoted phosphorylation on Tyr694 and additional tyrosine residue(s). Janus kinases (Jaks) were also constitutively associated with ErbB receptors and were phosphorylated in response to EGF-related ligands. However, we provide evidence that EGF- and neu differentiation factor-induced Stat activation are dependent on Src but not Jak kinases. Upon EGF stimulation, c-Src was rapidly recruited to Stat/ErbB receptor complexes. Pharmacological Src kinase inhibitors and a dominant negative c-Src ablated both Stat and Jak tyrosine phosphorylation. However, dominant negative Jaks did not affect EGF-induced Stat phosphorylation. Taken together, the experiments establish two independent roles for Src kinases: (i) key molecules in ErbB receptor-mediated Stat signaling and (ii) potential upstream regulators of Jak kinases.

Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
R. S. Finn
Targeting Src in breast cancer
Ann. Onc., May 16, 2008; (2008) mdn291v1.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Nagashima, T. Maruyama, H. Uchida, T. Kajitani, T. Arase, M. Ono, H. Oda, M. Kagami, H. Masuda, S. Nishikawa, et al.
Activation of SRC Kinase and Phosphorylation of Signal Transducer and Activator of Transcription-5 Are Required for Decidual Transformation of Human Endometrial Stromal Cells
Endocrinology, March 1, 2008; 149(3): 1227 - 1234.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Vigneron, E. Gamelin, and O. Coqueret
The EGFR-STAT3 Oncogenic Pathway Up-regulates the Eme1 Endonuclease to Reduce DNA Damage after Topoisomerase I Inhibition
Cancer Res., February 1, 2008; 68(3): 815 - 825.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
B. J. Dewar, O. S. Gardner, C.-S. Chen, H. S. Earp, J. M. Samet, and L. M. Graves
Capacitative Calcium Entry Contributes to the Differential Transactivation of the Epidermal Growth Factor Receptor in Response to Thiazolidinediones
Mol. Pharmacol., November 1, 2007; 72(5): 1146 - 1156.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. Herrmann, M. Vogt, M. Monnigmann, T. Clahsen, U. Sommer, S. Haan, V. Poli, P. C. Heinrich, and G. Muller-Newen
Nucleocytoplasmic shuttling of persistently activated STAT3
J. Cell Sci., September 15, 2007; 120(18): 3249 - 3261.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
S. Yang, M. A. Raymond-Stintz, W. Ying, J. Zhang, D. S. Lidke, S. L. Steinberg, L. Williams, J. M. Oliver, and B. S. Wilson
Mapping ErbB receptors on breast cancer cell membranes during signal transduction
J. Cell Sci., August 15, 2007; 120(16): 2763 - 2773.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. R. Pochampalli, B. G. Bitler, and J. A. Schroeder
Transforming Growth Factor {alpha} Dependent Cancer Progression Is Modulated by Muc1
Cancer Res., July 15, 2007; 67(14): 6591 - 6598.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
M. Perrais, X. Chen, M. Perez-Moreno, and B. M. Gumbiner
E-Cadherin Homophilic Ligation Inhibits Cell Growth and Epidermal Growth Factor Receptor Signaling Independently of Other Cell Interactions
Mol. Biol. Cell, June 1, 2007; 18(6): 2013 - 2025.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Cao, T. L. Tal, L. M. Graves, I. Gilmour, W. Linak, W. Reed, P. A. Bromberg, and J. M. Samet
Diesel exhaust particulate-induced activation of Stat3 requires activities of EGFR and Src in airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L422 - L429.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
G. Vlotides, M. Cruz-Soto, T. Rubinek, T. Eigler, C. J. Auernhammer, and S. Melmed
Mechanisms for Growth Factor-Induced Pituitary Tumor Transforming Gene-1 Expression in Pituitary Folliculostellate TtT/GF Cells
Mol. Endocrinol., December 1, 2006; 20(12): 3321 - 3335.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
F. HAYAKAWA and T. NAOE
SFK-STAT Pathway: An Alternative and Important Way to Malignancies
Ann. N.Y. Acad. Sci., November 1, 2006; 1086(1): 213 - 222.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
X. Liu, X. Gu, Z. Li, X. Li, H. Li, J. Chang, P. Chen, J. Jin, B. Xi, D. Chen, et al.
Neuregulin-1/erbB-Activation Improves Cardiac Function and Survival in Models of Ischemic, Dilated, and Viral Cardiomyopathy
J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1438 - 1447.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. M. Weaver and C. M. Silva
Modulation of Signal Transducer and Activator of Transcription 5b Activity in Breast Cancer Cells by Mutation of Tyrosines within the Transactivation Domain
Mol. Endocrinol., October 1, 2006; 20(10): 2392 - 2405.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Bose, H. Molina, A. S. Patterson, J. K. Bitok, B. Periaswamy, J. S. Bader, A. Pandey, and P. A. Cole
Phosphoproteomic analysis of Her2/neu signaling and inhibition
PNAS, June 27, 2006; 103(26): 9773 - 9778.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. P. Ng, Z. H. Cheung, and N. Y. Ip
STAT3 as a Downstream Mediator of Trk Signaling and Functions
J. Biol. Chem., June 9, 2006; 281(23): 15636 - 15644.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H.-W. Koon, D. Zhao, Y. Zhan, S. H. Rhee, M. P. Moyer, and C. Pothoulakis
Substance P Stimulates Cyclooxygenase-2 and Prostaglandin E2 Expression through JAK-STAT Activation in Human Colonic Epithelial Cells.
J. Immunol., April 15, 2006; 176(8): 5050 - 5059.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Tan, K.-H. Lan, J. Yao, C.-H. Lu, M. Sun, C. L. Neal, J. Lu, and D. Yu
Selective Inhibition of ErbB2-Overexpressing Breast Cancer In vivo by a Novel TAT-Based ErbB2-Targeting Signal Transducers and Activators of Transcription 3-Blocking Peptide.
Cancer Res., April 1, 2006; 66(7): 3764 - 3772.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Fang, E. M. Kofoed, B. M. Little, X. Wang, R. J. M. Ross, S. J. Frank, V. Hwa, and R. G. Rosenfeld
A Mutant Signal Transducer and Activator of Transcription 5b, Associated with Growth Hormone Insensitivity and Insulin-Like Growth Factor-I Deficiency, Cannot Function as a Signal Transducer or Transcription Factor
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1526 - 1534.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. V. Alvarez, H. Greulich, W. R. Sellers, M. Meyerson, and D. A. Frank
Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.
Cancer Res., March 15, 2006; 66(6): 3162 - 3168.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Jiang, H. Greulich, P. A. Janne, W. R. Sellers, M. Meyerson, and J. D. Griffin
Epidermal Growth Factor-Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression
Cancer Res., October 1, 2005; 65(19): 8968 - 8974.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. J. Gilbertson
ERBB2 in Pediatric Cancer: Innocent Until Proven Guilty
Oncologist, August 1, 2005; 10(7): 508 - 517.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
A. Vultur, R. Arulanandam, J. Turkson, G. Niu, R. Jove, and L. Raptis
Stat3 Is Required for Full Neoplastic Transformation by the Simian Virus 40 Large Tumor Antigen
Mol. Biol. Cell, August 1, 2005; 16(8): 3832 - 3846.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. K. Ayrapetov, N. H. Nam, G. Ye, A. Kumar, K. Parang, and G. Sun
Functional Diversity of Csk, Chk, and Src SH2 Domains due to a Single Residue Variation
J. Biol. Chem., July 8, 2005; 280(27): 25780 - 25787.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. E. Clark, C. C. Williams, T. T. Duplessis, K. L. Moring, A. R. Notwick, W. Long, W. S. Lane, I. Beuvink, N. E. Hynes, and F. E. Jones
ERBB4/HER4 Potentiates STAT5A Transcriptional Activity by Regulating Novel STAT5A Serine Phosphorylation Events
J. Biol. Chem., June 24, 2005; 280(25): 24175 - 24180.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
C. Proietti, M. Salatino, C. Rosemblit, R. Carnevale, A. Pecci, A. R. Kornblihtt, A. A. Molinolo, I. Frahm, E. H. Charreau, R. Schillaci, et al.
Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells
Mol. Cell. Biol., June 15, 2005; 25(12): 4826 - 4840.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Kario, M. D. Marmor, K. Adamsky, A. Citri, I. Amit, N. Amariglio, G. Rechavi, and Y. Yarden
Suppressors of Cytokine Signaling 4 and 5 Regulate Epidermal Growth Factor Receptor Signaling
J. Biol. Chem., February 25, 2005; 280(8): 7038 - 7048.
[Abstract] [Full Text] [PDF]

Home page
 Integr Cancer TherHome page
M. F. McCarty
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy
Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
L. Zhao, S. Hart, J. Cheng, J. J. Melenhorst, B. Bierie, M. Ernst, C. Stewart, F. Schaper, P. C. Heinrich, A. Ullrich, et al.
Mammary Gland Remodeling Depends on gp130 Signaling through Stat3 and MAPK
J. Biol. Chem., October 15, 2004; 279(42): 44093 - 44100.
[Abstract] [Full Text] [PDF]

Home page
 Crit. Rev. Oral Biol. Med.Home page
H. Siavash, N.G. Nikitakis, and J.J. Sauk
SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION: INSIGHTS INTO THE MOLECULAR BASIS OF ORAL CANCER
Crit. Rev. Oral. Biol. Med., September 1, 2004; 15(5): 298 - 307.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y. Zhang, Y.-Y. Cho, B. L. Petersen, F. Zhu, and Z. Dong
Evidence of STAT1 phosphorylation modulated by MAPKs, MEK1 and MSK1
Carcinogenesis, July 1, 2004; 25(7): 1165 - 1175.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
K.-U. Wagner, A. Krempler, A. A. Triplett, Y. Qi, N. M. George, J. Zhu, and H. Rui
Impaired Alveologenesis and Maintenance of Secretory Mammary Epithelial Cells in Jak2 Conditional Knockout Mice
Mol. Cell. Biol., June 15, 2004; 24(12): 5510 - 5520.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Goldshmit, C. E. Walters, H. J. Scott, C. J. Greenhalgh, and A. M. Turnley
SOCS2 Induces Neurite Outgrowth by Regulation of Epidermal Growth Factor Receptor Activation
J. Biol. Chem., April 16, 2004; 279(16): 16349 - 16355.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K.-O. Lai, Y. Chen, H.-M. Po, K.-C. Lok, K. Gong, and N. Y. Ip
Identification of the Jak/Stat Proteins as Novel Downstream Targets of EphA4 Signaling in Muscle: IMPLICATIONS IN THE REGULATION OF ACETYLCHOLINESTERASE EXPRESSION
J. Biol. Chem., April 2, 2004; 279(14): 13383 - 13392.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. P. M. Hughes, D. G. Thomas, T. J. Giordano, L. H. Baker, and K. T. McDonagh
Cell Surface Expression of Epidermal Growth Factor Receptor and Her-2 with Nuclear Expression of Her-4 in Primary Osteosarcoma
Cancer Res., March 15, 2004; 64(6): 2047 - 2053.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y.-J. Chang, M. J. Holtzman, and C.-C. Chen
Differential Role of Janus Family Kinases (JAKs) in Interferon-{gamma}-Induced Lung Epithelial ICAM-1 Expression: Involving Protein Interactions between JAKs, Phospholipase C{gamma}, c-Src, and STAT1
Mol. Pharmacol., March 1, 2004; 65(3): 589 - 598.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Ren, S. Meng, L. Mei, Z. J. Zhao, R. Jove, and J. Wu
Roles of Gab1 and SHP2 in Paxillin Tyrosine Dephosphorylation and Src Activation in Response to Epidermal Growth Factor
J. Biol. Chem., February 27, 2004; 279(9): 8497 - 8505.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
U. Vanhoefer, M. Tewes, F. Rojo, O. Dirsch, N. Schleucher, O. Rosen, J. Tillner, A. Kovar, A. H. Braun, T. Trarbach, et al.
Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor
J. Clin. Oncol., January 1, 2004; 22(1): 175 - 184.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
Z. Percario, E. Olivetta, G. Fiorucci, G. Mangino, S. Peretti, G. Romeo, E. Affabris, and M. Federico
Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery
J. Leukoc. Biol., November 1, 2003; 74(5): 821 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Xi, Q. Zhang, W. E. Gooding, T. E. Smithgall, and J. R. Grandis
Constitutive Activation of Stat5b Contributes to Carcinogenesis in Vivo
Cancer Res., October 15, 2003; 63(20): 6763 - 6771.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Minami, K. Yamamoto, H. Kiyoi, R. Ueda, H. Saito, and T. Naoe
Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia
Blood, October 15, 2003; 102(8): 2969 - 2975.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Buerger, K. Nagel-Wolfrum, C. Kunz, I. Wittig, K. Butz, F. Hoppe-Seyler, and B. Groner
Sequence-specific Peptide Aptamers, Interacting with the Intracellular Domain of the Epidermal Growth Factor Receptor, Interfere with Stat3 Activation and Inhibit the Growth of Tumor Cells
J. Biol. Chem., September 26, 2003; 278(39): 37610 - 37621.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Xi, Q. Zhang, K. F. Dyer, E. C. Lerner, T. E. Smithgall, W. E. Gooding, J. Kamens, and J. R. Grandis
Src Kinases Mediate STAT Growth Pathways in Squamous Cell Carcinoma of the Head and Neck
J. Biol. Chem., August 22, 2003; 278(34): 31574 - 31583.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. S. Laszlo and N. M. Nathanson
Src Family Kinase-independent Signal Transduction and Gene Induction by Leukemia Inhibitory Factor
J. Biol. Chem., July 18, 2003; 278(30): 27750 - 27757.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Shao, H. Y. Cheng, R. G. Cook, and D. J. Tweardy
Identification and Characterization of Signal Transducer and Activator of Transcription 3 Recruitment Sites within the Epidermal Growth Factor Receptor
Cancer Res., July 15, 2003; 63(14): 3923 - 3930.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Tidcombe, A. Jackson-Fisher, K. Mathers, D. F. Stern, M. Gassmann, and J. P. Golding
Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality
PNAS, July 8, 2003; 100(14): 8281 - 8286.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
R.-A. Wang, R. K. Vadlamudi, R. Bagheri-Yarmand, I. Beuvink, N. E. Hynes, and R. Kumar
Essential functions of p21-activated kinase 1 in morphogenesis and differentiation of mammary glands
J. Cell Biol., May 12, 2003; 161(3): 583 - 592.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. B. Kabotyanski and J. M. Rosen
Signal Transduction Pathways Regulated by Prolactin and Src Result in Different Conformations of Activated Stat5b
J. Biol. Chem., May 2, 2003; 278(19): 17218 - 17227.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. A. Feltus, W. J. Kovacs, W. Nicholson, C. M. Silva, S. K. Nagdas, N. A. Ducharme, and M. H. Melner
Epidermal Growth Factor Increases Cortisol Production and Type II 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4-Isomerase Expression in Human Adrenocortical Carcinoma Cells: Evidence for a Stat5-Dependent Mechanism
Endocrinology, May 1, 2003; 144(5): 1847 - 1853.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. L. Leong, G. A. Andrews, D. E. Johnson, K. F. Dyer, S. Xi, J. C. Mai, P. D. Robbins, S. Gadiparthi, N. A. Burke, S. F. Watkins, et al.
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
PNAS, April 1, 2003; 100(7): 4138 - 4143.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Anido, P. Matar, J. Albanell, M. Guzman, F. Rojo, J. Arribas, S. Averbuch, and J. Baselga
ZD1839, a Specific Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor, Induces the Formation of Inactive EGFR/HER2 and EGFR/HER3 Heterodimers and Prevents Heregulin Signaling in HER2-overexpressing Breast Cancer Cells
Clin. Cancer Res., April 1, 2003; 9(4): 1274 - 1283.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Olivetta, Z. Percario, G. Fiorucci, G. Mattia, I. Schiavoni, C. Dennis, J. Jager, M. Harris, G. Romeo, E. Affabris, et al.
HIV-1 Nef Induces the Release of Inflammatory Factors from Human Monocyte/Macrophages: Involvement of Nef Endocytotic Signals and NF-{kappa}B Activation
J. Immunol., February 15, 2003; 170(4): 1716 - 1727.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler
The Role of Prolactin in Mammary Carcinoma
Endocr. Rev., February 1, 2003; 24(1): 1 - 27.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. T. Kloth, K. K. Laughlin, J. S. Biscardi, J. L. Boerner, S. J. Parsons, and C. M. Silva
STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor
J. Biol. Chem., January 10, 2003; 278(3): 1671 - 1679.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
A. A. Habib, S. J. Chun, B. G. Neel, and T. Vartanian
Increased Expression of Epidermal Growth Factor Receptor Induces Sequestration of Extracellular Signal-Related Kinases and Selective Attenuation of Specific Epidermal Growth Factor-Mediated Signal Transduction Pathways
Mol. Cancer Res., January 1, 2003; 1(3): 219 - 233.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
M. N. Le, R. A. Kohanski, L.-H. Wang, and H. B. Sadowski
Dual Mechanism of Signal Transducer and Activator of Transcription 5 Activation by the Insulin Receptor
Mol. Endocrinol., December 1, 2002; 16(12): 2764 - 2779.
[Abstract] [Full Text] [PDF]